Can-Fite BioPharma (CANF) Net Margin Growth (1y) (2016 - 2023)
Powered by 
Analysis
Can-Fite BioPharma (CANF) Net Margin Growth (1y) (2016 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.12 Bn | 628.36 Bn | 17.26 Bn | -146.00 |
| 2 | AbbVie | 445.86 Bn | 439.29 Bn | 12.70 Bn | 1,518.00 |
| 3 | Merck | 362.13 Bn | 354.99 Bn | 12.21 Bn | -3,607.00 |
| 4 | Novartis Ag | 268.88 Bn | 261.19 Bn | 11.24 Bn | -610.00 |
| 5 | Pfizer | 156.96 Bn | 145.26 Bn | 10.94 Bn | -2,157.00 |
| 6 | Sanofi | 52.26 Bn | 44.88 Bn | 10.79 Bn | -3,647.00 |
| 7 | Revolution Medicines | 42.98 Bn | 42.98 Bn | - | - |
| 8 | Incyte | 25.13 Bn | 20.59 Bn | 1.57 Bn | 166.00 |
| 9 | United Therapeutics | 21.56 Bn | 18.90 Bn | 683.80 Mn | 376.00 |
| 10 | Can-Fite BioPharma | 1.80 Mn | -1.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -27,400.00 |
| Sep 30, 2023 | 30,974.00 |
| Jun 30, 2023 | 10,800.00 |
| Mar 31, 2023 | -11,370.00 |
| Dec 31, 2022 | 106,528.00 |
| Sep 30, 2022 | 415,466.00 |
| Jun 30, 2022 | -159,913.00 |
| Mar 31, 2022 | 8,160.00 |
| Dec 31, 2021 | 39,416.00 |
| Sep 30, 2021 | 428,786.00 |
| Jun 30, 2021 | -407,618.00 |
| Dec 31, 2020 | -127,387.00 |
| Sep 30, 2020 | -995,969.00 |
| Jun 30, 2020 | 844,767.00 |
| Dec 31, 2019 | 226,611.00 |
| Sep 30, 2019 | 24,917.00 |
| Jun 30, 2019 | -331,705.00 |
| Mar 31, 2019 | 79,806.00 |
| Dec 31, 2018 | 768,145.00 |
| Sep 30, 2018 | -20,031.00 |